ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,239,276 | -15.5% | 625,496 | -12.9% | 0.01% | -13.3% |
Q2 2023 | $2,649,892 | -18.4% | 718,128 | -26.8% | 0.02% | -31.8% |
Q1 2023 | $3,247,875 | +6.0% | 981,231 | +24.3% | 0.02% | -15.4% |
Q4 2022 | $3,062,864 | +117.4% | 789,398 | +36.1% | 0.03% | +73.3% |
Q3 2022 | $1,409,000 | – | 579,850 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |